Evidence map›Paper›PMID 34367741›Full record

ArticleCureus2021

Association Between Race/Ethnicity and Survival in Women With Advanced Ovarian Cancer.

Justin J Cheng, Bu Jung Kim, Catherine Kim, Pura Rodriguez de la Vega, Marcia Varella, Carolyn D Runowicz, Juan Ruiz-Pelaez

Open access · diamondAbstract read
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Justin J ChengDepartment of Translational Medicine, Florida International University, Herbert Wertheim College of Medicine, Miami, USA.
Bu Jung KimDepartment of Translational Medicine, Florida International University, Herbert Wertheim College of Medicine, Miami, USA.
Catherine KimDepartment of Translational Medicine, Florida International University, Herbert Wertheim College of Medicine, Miami, USA.
Pura Rodriguez de la VegaDepartment of Translational Medicine, Florida International University, Herbert Wertheim College of Medicine, Miami, USA.
Marcia VarellaDepartment of Translational Medicine, Florida International University Herbert Wertheim College of Medicine, Miami, USA.
Carolyn D RunowiczDepartment of Academic Affairs, Florida International University, Herbert Wertheim College of Medicine, Miami, USA.
Juan Ruiz-PelaezDepartment of Translational Medicine, Florida International University Herbert Wertheim College of Medicine, Miami, USA.
Kannur Medical College · INFlorida International University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Ovarian cancer is the fifth-leading cause of cancer-related mortality in US women. There are survival disparities between non-Hispanic black (NHB) and non-Hispanic white (NHW) women. We assessed if insurance status or extent of disease modified the effect of race/ethnicity on survival for ovarian cancer. Methods A historical cohort was assembled using the 2007-2015 National Cancer Institute's Surveillance, Epidemiology, and End Result (SEER) dataset. Adult NHB and NHW (>18 years) diagnosed with regional and distant ovarian cancer were included. The outcome was five-year cause-specific mortality. Multivariable Cox regression models were fitted, including race by the extent of disease and race by insurance status interaction terms. Results For each significant interaction, separate Cox models were fitted. In total 8,043 women were included. The insurance status/race interaction was not statistically significant, but the extent of disease modified the effect of race on survival. NHB survival was lower in regional disease (adjusted hazard ratio (HR) =1.6; 95% confidence interval (CI) 1.1-2.4), while there was no difference in survival between women with distant disease (adjusted HR =1.0; 95%CI 0.9-1.2). Conclusions Ovarian cancer mortality is similar between NHB and NHW women with the distant disease but higher in NHB women with regional disease. Further research should clarify whether this difference is due to access to quality cancer treatment or other factors affecting treatment response.

Indexed as

ethnicityhealth disparityovarian cancerracesurvival

Identifiers

PMID34367741
PMCPMC8330386
OpenAlexW3173878670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.